A Randomised, Double-blind, Placebo-controlled, Single-dose, Parallel Group Trial With Insulin 454 and SIAM 50 in Healthy Male Japanese Subjects
Latest Information Update: 07 Nov 2021
At a glance
- Drugs Insulin degludec (Primary) ; Insulin degludec/insulin aspart (Primary)
- Indications Type 1 diabetes mellitus; Type 2 diabetes mellitus
- Focus Adverse reactions
- 14 Jun 2013 New trial record